Seizure progression triggered by IQSEC3 loss is mitigated by reducing activated microglia in mice

Dongseok Park1, Seungjoon Kim1, Hyeonho Kim1

  • 1Department of Brain and Cognitive Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, South Korea.

Glia
|July 10, 2020
PubMed

Insights

Loss of IQSEC3 (a guanine nucleotide exchange factor) leads to microglial activation and seizures. Inhibiting microglial activation prevents neuron death and seizures in IQSEC3-deficient mice, suggesting a new epilepsy management strategy.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Epilepsy Research

Background:

  • IQSEC3, an ADP-ribosylation factor guanine nucleotide exchange factor (ARF-GEF), is crucial for GABAergic synapses.
  • Loss of IQSEC3 in mice elevates seizure susceptibility, but the role of microglia remains unknown.

Purpose of the Study:

  • To investigate the contribution of microglia to epileptogenesis in IQSEC3-deficient mice.
  • To explore minocycline's effect on neuronal death and seizures in IQSEC3 knockdown models.

Main Methods:

  • Hippocampal dentate gyrus (DG)-specific IQSEC3 knockdown (KD) in mice.
  • Assessment of microglial activation, DG granule cell death, and spontaneous seizures.
  • Treatment with minocycline, a microglial activation inhibitor.

Main Results:

  • IQSEC3 KD mice showed microglial activation and DG granule neuron death.
  • Minocycline treatment prevented neuron death and seizures in IQSEC3 KD mice.
  • Minocycline did not affect GABAergic synapse deficits or somatostatin loss.

Conclusions:

  • Microglial activation contributes to IQSEC3 KD-induced epileptogenesis.
  • Inhibiting microglial activation may offer a novel therapeutic strategy for epilepsy management.